On‐label use of sodium–glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetes

AIMS/INTRODUCTION: This study aimed to investigate the risk of diabetic ketoacidosis (DKA) in insulin‐treated type 1 diabetes patients administered sodium–glucose cotransporter 2 (SGLT2) inhibitors in real‐world clinical practice. MATERIALS AND METHODS: We carried out a real‐world, retrospective, ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Horii, Takeshi, Oikawa, Yoichi, Atsuda, Koichiro, Shimada, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409873/
https://www.ncbi.nlm.nih.gov/pubmed/33448127
http://dx.doi.org/10.1111/jdi.13506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409873/
https://www.ncbi.nlm.nih.gov/pubmed/33448127
http://dx.doi.org/10.1111/jdi.13506

Ejemplares similares